COVID-19 impact on therapy drug sales growth in India 2020 by type

Respiratory therapy drugs witnessed the highest sales across India in March 2020 compared to February that same year, recording a growth of nearly 23 percent. This was due to the coronavirus (COVID-19) epidemic and despite a nation-wide lockdown that disrupted distribution of drugs and prescription medicines. On the other hand, segments such as dermatology, gastrointestinal, pain and analgesics, and vaccines showed a decline in sales during the same time period.
The country went into lockdown earlier that week, the largest in the world, restricting 1.3 billion people.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.